Rational choices for allocating antiretrovirals in Africa: Treatment equity, epidemiological efficiency, and feasibility
2006

Rationing Antiretroviral Therapy for HIV/AIDS in Africa

publication Evidence: moderate

Author Information

Author(s): David P. Wilson, Sally M. Blower

Hypothesis

Targeting HIV virologic core groups for antiretroviral therapy allocation will improve treatment equity and epidemiological efficiency.

Conclusion

Targeting HIV virologic core groups for treatment can enhance equity and efficiency in antiretroviral therapy allocation in Africa.

Supporting Evidence

  • Targeting virologic core groups has been shown to effectively reduce herpes incidence.
  • Treatment equity is only achievable in some areas of South Africa with large catchment areas for healthcare facilities.
  • Mathematical models can help decide how to allocate scarce antiretrovirals to achieve treatment equity.

Takeaway

This study suggests that instead of focusing on high-risk groups, we should treat those with the highest viral loads to help more people with HIV in Africa.

Methodology

The study uses mathematical modeling and operational research methodology to evaluate antiretroviral allocation strategies.

Limitations

The feasibility of implementing suggested strategies may vary significantly across different African countries.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030160

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication